Skip to content

A single group study to asses the effect of Jatamamsi capsule in social anxiety patients

An open label single arm clinical study to evaluate the effect of Jatamamsi capsule in Social Anxiety Disorder W.S.R to chittodvdega - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109400
Enrollment
30
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F401- Social phobias

Interventions

None listed

Sponsors

DR GOPIKA RAMACHANDRAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Individuals fulfilling diagnostic criteria of Social anxiety disorder as per DSM-5. Presenting with at least criteria no.1, 2, 3, 6 and 8. with or without the presence of other symptoms. 2) Atichintana, Bhaya 3) Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1)Patients suffering from any systemic illness, Agoraphobia, Panic disorder, Generalized anxiety disorder, Separation anxiety disorder, Specific phobia, Major depressive disorder, Personality disorder and other metabolic disorders interfering with the treatment protocol. 2) Pregnant and lactating women. 3) Patient suffering from consequences of substance abuse.

Design outcomes

Primary

MeasureTime frame
Significant decrease in symptoms of Social anxiety disorder based on subjective criteria. Timepoint: Parameters will be scored by standard method and will be assessed before and after treatment on, 30th day.

Secondary

MeasureTime frame
NILTimepoint:

Countries

India

Contacts

Public ContactDR GOPIKA RAMACHANDRAN

SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA, HOSPITAL AND RESEARCH CENTRE

dhanuchil@gmail.com9900554202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026